ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker

Interleukin enhancer-binding factor 3 (ILF3) may function as a transcriptional coactivator and has been reported to be involved in tumor proliferation and metastasis; however, its role and clinical value in gastric cancer (GC) remains unclear. To understand the value of ILF3 in GC, a total of 80 mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yü, Li, Yong, Zhao, Yijie, Liu, Yang, Fan, Liqiao, Jia, Nan, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579973/
https://www.ncbi.nlm.nih.gov/pubmed/31115508
http://dx.doi.org/10.3892/mmr.2019.10229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579973/
https://www.ncbi.nlm.nih.gov/pubmed/31115508
http://dx.doi.org/10.3892/mmr.2019.10229

Ejemplares similares